We report a case of a patient with highly active anti-retroviral therapy-resistant human immunodeficiency virus (HIV)-associated progressive multifocal leukoencephalopathy (PML). The patient showed an improvement in imaging findings and clinical symptoms after mefloquine was introduced as an additional treatment. Serial assessment of white matter lesions was conducted by proton magnetic resonance spectroscopy (1HMRS) and diffusion-weighted imaging (DWI). As the clinical symptoms improved, the N-acetylaspartate/creatine ratio increased, the choline/creatine ratio decreased, and the elevated ADC value decreased. These concomitant changes suggested that 1H-MRS and DWI were useful for the assessment of the therapeutic effect on PML. © 2012 The Japanese Society of Internal Medicine.
CITATION STYLE
Naito, K., Ueno, H., Sekine, M., Kanemitsu, M., Ohshita, T., Nakamura, T., … Matsumoto, M. (2012). Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: A serial multimodal MRI study. Internal Medicine, 51(2), 205–209. https://doi.org/10.2169/internalmedicine.51.6253
Mendeley helps you to discover research relevant for your work.